Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials – MedCity News

Grove AI, an artificial intelligence startup focused on clinical trials, was acquired approximately two years after its founding, according to MedCity News. The acquisition marks a rapid exit for the company, which developed technology aimed at transforming how clinical trials operate. Details regarding the acquiring company and acquisition terms were not specified in the available description.

Read Full Article →